HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 357 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $8,188,853 | -73.9% | 214,424 | -61.1% | 0.02% | -76.5% |
| Q4 2022 | $31,356,111 | +640.2% | 551,074 | +414.4% | 0.10% | +600.0% |
| Q3 2022 | $4,236,000 | -83.1% | 107,139 | -81.2% | 0.01% | -83.1% |
| Q2 2022 | $25,099,000 | +351.6% | 570,431 | +309.3% | 0.08% | +418.8% |
| Q1 2022 | $5,558,000 | +25.3% | 139,362 | +27.8% | 0.02% | +60.0% |
| Q3 2021 | $4,435,000 | -73.1% | 109,013 | -70.0% | 0.01% | -73.0% |
| Q2 2021 | $16,488,000 | -5.0% | 363,100 | -12.8% | 0.04% | -17.8% |
| Q1 2021 | $17,359,000 | +43.4% | 416,380 | +46.9% | 0.04% | +28.6% |
| Q4 2020 | $12,107,000 | +8.5% | 283,471 | -33.2% | 0.04% | -12.5% |
| Q3 2020 | $11,160,000 | -46.2% | 424,673 | -45.2% | 0.04% | -61.2% |
| Q2 2020 | $20,758,000 | +4.4% | 774,255 | -29.9% | 0.10% | -36.4% |
| Q1 2020 | $19,874,000 | -34.2% | 1,104,738 | -35.2% | 0.16% | +78.0% |
| Q4 2019 | $30,222,000 | +419.5% | 1,704,582 | +354.5% | 0.09% | +355.0% |
| Q3 2019 | $5,818,000 | -29.7% | 375,083 | -22.1% | 0.02% | -28.6% |
| Q2 2019 | $8,271,000 | +2347.0% | 481,418 | +2196.4% | 0.03% | +2700.0% |
| Q1 2019 | $338,000 | -44.7% | 20,964 | -49.8% | 0.00% | -50.0% |
| Q4 2018 | $611,000 | -92.9% | 41,746 | -91.1% | 0.00% | -91.3% |
| Q3 2018 | $8,557,000 | +24.4% | 470,966 | +15.5% | 0.02% | +9.5% |
| Q2 2018 | $6,877,000 | -68.5% | 407,656 | -63.5% | 0.02% | -71.2% |
| Q1 2018 | $21,862,000 | +3.6% | 1,115,986 | +7.1% | 0.07% | +5.8% |
| Q4 2017 | $21,104,000 | +55.4% | 1,041,676 | +33.3% | 0.07% | +43.8% |
| Q3 2017 | $13,578,000 | +170.6% | 781,691 | +99.7% | 0.05% | +166.7% |
| Q2 2017 | $5,018,000 | +1606.8% | 391,412 | +2207.7% | 0.02% | +1700.0% |
| Q4 2015 | $294,000 | -89.6% | 16,961 | -92.0% | 0.00% | -92.9% |
| Q3 2015 | $2,830,000 | +1308.0% | 210,719 | +2272.2% | 0.01% | +1300.0% |
| Q2 2015 | $201,000 | – | 8,883 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 7,048,282 | $126,799,000 | 27.23% |
| First Light Asset Management, LLC | 1,630,591 | $29,334,000 | 5.01% |
| SNYDER CAPITAL MANAGEMENT L P | 3,393,057 | $61,041,000 | 3.48% |
| Bellevue Group AG | 7,663,956 | $137,874,000 | 2.67% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 307,633 | $5,531,000 | 2.52% |
| Lombard Odier Asset Management (Switzerland) SA | 900,000 | $16,191,000 | 2.17% |
| Elk Creek Partners, LLC | 654,362 | $11,772,000 | 2.02% |
| DOHENY ASSET MANAGEMENT /CA | 127,110 | $2,254,000 | 1.79% |
| Granite Investment Partners, LLC | 1,277,438 | $22,981,000 | 1.49% |
| Amia Capital LLP | 69,409 | $1,249,000 | 1.11% |